Literature DB >> 26465287

Clinical and genetic basis of familial amyotrophic lateral sclerosis.

Paulo Victor Sgobbi de Souza1, Wladimir Bocca Vieira de Rezende Pinto1, Marco Antônio Troccoli Chieia1, Acary Souza Bulle Oliveira1.   

Abstract

Amyotrophic lateral sclerosis represents the most common neurodegenerative disease leading to upper and lower motor neuron compromise. Although the vast majority of cases are sporadic, substantial gain has been observed in the knowledge of the genetic forms of the disease, especially of familial forms. There is a direct correlation between the profile of the mutated genes in sporadic and familial forms, highlighting the main role of C9orf72 gene in the clinical forms associated with frontotemporal dementia spectrum. The different genes related to familial and sporadic forms represent an important advance on the pathophysiology of the disease and genetic therapeutic perspectives, such as antisense therapy. The objective of this review is to signal and summarize clinical and genetic data related to familial forms of amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26465287     DOI: 10.1590/0004-282X20150161

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  6 in total

Review 1.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks.

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Gabriel Novaes de Rezende Batistella; Thiago Bortholin; Acary Souza Bulle Oliveira
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

2.  Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.

Authors:  Frank W Pun; Bonnie Hei Man Liu; Xi Long; Hoi Wing Leung; Geoffrey Ho Duen Leung; Quinlan T Mewborne; Junli Gao; Anastasia Shneyderman; Ivan V Ozerov; Ju Wang; Feng Ren; Alexander Aliper; Evelyne Bischof; Evgeny Izumchenko; Xiaoming Guan; Ke Zhang; Bai Lu; Jeffrey D Rothstein; Merit E Cudkowicz; Alex Zhavoronkov
Journal:  Front Aging Neurosci       Date:  2022-06-28       Impact factor: 5.702

Review 3.  Secondary Metabolites with Antioxidant Activities for the Putative Treatment of Amyotrophic Lateral Sclerosis (ALS): "Experimental Evidences".

Authors:  Jamire M Silva; Michelangela S C Nobre; Sonaly L Albino; Lucas L Lócio; Agnis P S Nascimento; Luciana Scotti; Marcus T Scotti; João A Oshiro-Junior; Maria C A Lima; Francisco J B Mendonça-Junior; Ricardo O Moura
Journal:  Oxid Med Cell Longev       Date:  2020-11-24       Impact factor: 6.543

4.  Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity?

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Igor Braga Farias; Bruno de Mattos Lombardi Badia; Icaro França Navarro Pinto; Gustavo Carvalho Costa; Carolina Maria Marin; Ana Carolina Dos Santos Jorge; Emília Correia Souto; Paulo de Lima Serrano; Roberta Ismael Lacerda Machado; Marco Antônio Troccoli Chieia; Enrico Bertini; Acary Souza Bulle Oliveira
Journal:  Orphanet J Rare Dis       Date:  2021-08-11       Impact factor: 4.123

5.  Homozygous ALS-linked FUS P525L mutations cell- autonomously perturb transcriptome profile and chemoreceptor signaling in human iPSC microglia.

Authors:  Sze Yen Kerk; Yu Bai; Janell Smith; Pranav Lalgudi; Charleen Hunt; Junko Kuno; John Nuara; Tao Yang; Kathryn Lanza; Newton Chan; Angel Coppola; Qian Tang; Jennifer Espert; Henderson Jones; Casey Fannell; Brian Zambrowicz; Eric Chiao
Journal:  Stem Cell Reports       Date:  2022-02-03       Impact factor: 7.294

Review 6.  Cognitive dysfunction in hereditary spastic paraplegias and other motor neuron disorders.

Authors:  Ingrid Faber; Lucas Melo T Branco; Marcondes Cavalvante França Júnior
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.